GeneDx Holdings Corp. Increase (Decrease) in Other Operating Assets
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Other Operating Assets of -$416.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2023-08-08
- GeneDx Holdings Corp. increase (decrease) in other operating assets for the quarter ending 2023-06-30 was -$471.00K, a 148.31% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other operating assets for the quarter ending 2023-03-31 was $55.00K, a 63.58% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was -$1.35M, a 173.37% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was $229.00K, a 1247.06% increase year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other operating assets for fiscal 2022 was $2.00K, a 99.89% decline from fiscal 2021.
- GeneDx Holdings Corp. increase (decrease) in other operating assets for fiscal 2021 was $1.86M.
- GeneDx Holdings Corp. increase (decrease) in other operating assets for fiscal 2020 was -$1.18M, a 126.73% decline from fiscal 2019.
- GeneDx Holdings Corp. increase (decrease) in other operating assets for fiscal 2019 was $4.39M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$471.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$416.00K 10-Q · filed 2023-08-08 | -$1.77M derived: sum of 3 quarters · filed 2023-08-08 | -$1.54M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $55.00K 10-Q · filed 2023-05-09 | -$1.30M derived: sum of 2 quarters · filed 2023-05-09 | -$1.07M derived: sum of 3 quarters · filed 2023-05-09 | -$94.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$1.12M derived: sum of 2 quarters · filed 2023-03-16 | -$149.00K derived: sum of 3 quarters · filed 2023-08-08 | $2.00K 10-K · filed 2023-03-16 |
| 2022-09-30 | $229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.20M derived: sum of 2 quarters · filed 2023-08-08 | $1.35M 10-Q · filed 2022-11-14 | $3.20M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $975.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.13M 10-Q · filed 2023-08-08 | $2.97M derived: sum of 3 quarters · filed 2023-08-08 | $2.99M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $151.00K 10-Q · filed 2023-05-09 | $2.00M derived: sum of 2 quarters · filed 2023-05-09 | $2.01M derived: sum of 3 quarters · filed 2023-05-09 | $2.01M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.86M derived: sum of 2 quarters · filed 2023-03-16 | $1.86M derived: sum of 3 quarters · filed 2023-03-16 | $1.86M 10-K · filed 2023-03-16 |
| 2021-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $17.00K derived: sum of 2 quarters · filed 2022-11-14 | $17.00K 10-Q · filed 2022-11-14 | $16.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | -$1.00K derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | -$1.00K derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$1.18M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | -$1.17M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $4.39M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |